Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated active pharmaceutical ingredients (APIs) where enhanced metabolic stability and bioavailability are required. Its structure supports the creation of chiral molecules, making it valuable in asymmetric synthesis for drugs targeting central nervous system disorders and anti-inflammatory agents. Commonly employed in the preparation of prostaglandin analogs and other bioactive compounds where fluorine substitution improves binding affinity and resistance to enzymatic degradation. Also utilized in agrochemicals for developing herbicides and pesticides with improved environmental stability and target specificity.